本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cytek BioSciences

4.93
+0.04000.82%
盤後4.90-0.0300-0.61%16:15 EDT
成交量:155.53萬
成交額:761.15萬
市值:6.41億
市盈率:-7.83
高:5.01
開:4.89
低:4.77
收:4.89
52周最高:6.18
52周最低:3.28
股本:1.30億
流通股本:1.03億
量比:1.21
換手率:1.51%
股息:- -
股息率:- -
每股收益(TTM):-0.6300
每股收益(LYR):-0.5209
淨資產收益率:-23.04%
總資產收益率:-6.31%
市淨率:1.99
市盈率(LYR):-9.46

資料載入中...

2024/04/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/19

重要事件披露

Form 8-K - Current report
2024/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/22

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/09

重要事件披露

Form 8-K - Current report
2023/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/07

重要事件披露

Form 8-K - Current report